Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis

J Neuroimmunol. 2016 May 15:294:32-40. doi: 10.1016/j.jneuroim.2016.03.009. Epub 2016 Mar 19.

Abstract

The development of multiple sclerosis, a major neurodegenerative disease, is due to both genetic and environmental factors that might trigger aberrant epigenetic changes of the genome. In this study, we analysed global DNA methylation in the brain of mice upon induction of experimental autoimmune encephalomyelitis (EAE), and the effect of environmental enrichment (EE). We demonstrate that global DNA methylation decreased in the striatum, but not in the cortex, of EAE mice compared to healthy controls, in particular in neuronal nitric oxide synthase (nNOS)-positive interneurons of this brain area. Also, in the striatum but again not in the cortex, decreased DNA methylation of the nNOS downstream effector, dexamethasone-induced Ras protein 1 (Dexras 1), was observed in EAE mice, and was paralleled by an increase in its mRNA. Interestingly, EE was able to revert EAE effects on mRNA expression and DNA methylation levels of Dexras 1 and reduced gene expression of nNOS and 5-lipoxygenase (Alox5). Conversely, interleukin-1β (IL-1β) gene expression was found up-regulated in EAE mice compared to controls and was not affected by EE. Taken together, these data demonstrate an unprecedented epigenetic modulation of nNOS-signaling in the pathogenesis of multiple sclerosis, and show that EE can specifically revert EAE effects on Dexras 1 along this pathway.

Keywords: DNA methylation; Dexras 1; Environmental enrichment; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuronal NOS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5-Methylcytosine / metabolism
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Arachidonate 5-Lipoxygenase / metabolism
  • Brain / drug effects
  • Brain / metabolism*
  • Brain / pathology
  • Cytokines / genetics
  • Cytokines / metabolism
  • Dexamethasone / pharmacology
  • Disease Models, Animal
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / metabolism
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / metabolism
  • Encephalomyelitis, Autoimmune, Experimental / pathology*
  • Epigenesis, Genetic / drug effects
  • Epigenesis, Genetic / physiology*
  • Female
  • Mice
  • Mice, Inbred C57BL
  • Myelin-Oligodendrocyte Glycoprotein / immunology
  • Neurons / metabolism
  • Nitric Oxide Synthase Type I / metabolism*
  • Peptide Fragments / immunology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • ras Proteins / genetics
  • ras Proteins / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • myelin oligodendrocyte glycoprotein (35-55)
  • 5-Methylcytosine
  • Dexamethasone
  • Arachidonate 5-Lipoxygenase
  • Nitric Oxide Synthase Type I
  • Rasd1 protein, mouse
  • ras Proteins